Rimonabant in obese patients with type 2 diabetes

Lancet. 2007 Feb 17;369(9561):553; author reply 554-5. doi: 10.1016/S0140-6736(07)60261-X.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Depression / chemically induced
  • Diabetes Mellitus, Type 2 / complications
  • Humans
  • Obesity / complications
  • Obesity / drug therapy*
  • Piperidines / adverse effects
  • Piperidines / therapeutic use*
  • Pyrazoles / adverse effects
  • Pyrazoles / therapeutic use*
  • Rimonabant
  • Weight Loss / drug effects*

Substances

  • Piperidines
  • Pyrazoles
  • Rimonabant